Navigation Links
Global Growth Factors (Blood And Tissue) Industry
Date:7/3/2012

Cole Eye Institute Offers TIMP-3 Mechanism for Preventing

Abnormal Growth of Blood Vessels II-23

Effect of Brain Derived Neurotrophic Factor on Retinal Cells II-23

Orcel™ Exhibits High Growth Factor for Wound Healing and

Cardiovascular Applications II-24

Drug Combination of Macrophage Colony Stimulating Factor Shows

Successful Tolerance Levels II-24

Neotrofin™ Triggers Neurotrophic Factors II-24

G-CSF Shows Capability for Promoting Neutrophil Production II-25

Insulin-like Growth Factor-1 (IGF) Gene Transfer Accelerates

Wound Healing Process II-25

Hepatocyte Growth Factors - Exhibiting Dual Role II-26

Cortex Pharmaceuticals Ampakines® Promotes Expression of

Neurotrophin II-26

Granulocyte Colony Stimulating Factor Finds Application in

Treating Neonates II-26

Cerebrolysin Promotes Cognition II-26

6. BREAKTHROUGHS - A RECENT PAST REVIEW II-27Novel Set of Human Cytokines Unveiled II-27IGFBP-3 and its Potential to Ward Off Gastric Cancer II-27Bone Morphogenic Proteins Show Potential for MusculoskeletalRegeneration II-27Growth Factors - Their Role in Preventing Heart Stroke II-27Growth Factor Proteins Show Promising Results for Treating Cancer II-27Neurotrophic Growth Factor - Primarily Responsible for Loss ofVision II-28Redox-Active Grape Seed Exhibits Favorable Properties forDermal Wound Healing II-28Role of Brain-Derived Neurotrophic Factor on Memory II-28Nerve Growth Factor Found to Enhance Barium Current andInsulin Secretion II-28Lipid Peroxidation May be Associated with Wound Healing II-29Genentech Inc Unveils Molecule for Stimulating Growth of BloodVessels II-29Connective Tissue Growth Factor Found to Promote Lung Fibroblast II-29Influence of Insulin-Like Growth Factor on Growth II-30Regeneron Discovers Angiopoietins Targeted at Blood VesselGrowth and Repair II-30Environment and Insulin-Like Growth Factors Stimulate Risk ofCancer
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Global Angiogenesis Inhibitors and Stimulators Industry
2. MarketsandMarkets: Global Healthcare Cloud Computing Market Worth $5,419.8 Million by 2017
3. Global Electrodes for Medical Devices Industry
4. NeuroSigma Receives Global Quality Control Certification
5. MarketsandMarkets: Global Radiotherapy Devices Market Worth $5.8 Billion by 2016
6. Demand for Product Pipeline Review and Analysis Rises in the Global Pharma Industry
7. 3SBio Obtains SFDA Approval to Join Global Phase III Trial for Voclosporin
8. Global Drug-Eluting Stents Industry
9. Global Pain Management Industry
10. Pharmaceuticals: Global Industry Almanac, MarketLine
11. Global Information, Inc. Announces New Market Forecasts For Drug Discovery Industry as it Emerges from Recession
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013   Accuray ... today the publication of study results involving hundreds ... Robotic Radiosurgery System, the most widely used form ... study followed 304 patients for a median of ... and found that 97 percent of patients with ...
(Date:5/21/2013)... CITY, Calif. , May 21, 2013 ... point-of-care blood analysis systems, announced today that ... present at the Stifel Annual Dental & Veterinary Conference ... The conference will be held at Le Parker Meridien ... About Abaxis Abaxis develops, manufactures, ...
(Date:5/21/2013)... , May 21, 2013 Ceregene, Inc. ... analysis of its double-blind, randomized, controlled Phase 2b ... gene therapy product designed to deliver the neurotrophic ... identified a more robust response to CERE-120 in ... treatment relative to those diagnosed 10 years or ...
Breaking Medicine Technology:New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5
... 7 NeuroVasx, Inc. announced,today the completion of a private ... of Minneapolis, MN and the Stephens Group of Little,Rock, AR. ... also announced completion of long term follow up on 20,patients ... which was completed in May. The company intends to announce ...
... Genomic Health,Inc. (Nasdaq: GHDX ) today announced ... DX(R) breast cancer test are scheduled to be ... Symposium, taking place,December 13-16, 2007. Oncotype DX is ... the likelihood of recurrence and the likelihood,of chemotherapy ...
Cached Medicine Technology:Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium 2Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium 3
(Date:5/21/2013)... Long Beach, CA (PRWEB) May 21, 2013 ... the 3rd Annual EB-5 Investment Summit: Dealmakers Conference ... The Dealmakers Conference will focus on exploring alternative ... will provide the latest market, legal and economic ... executives, immigration and legal professionals within the EB-5 ...
(Date:5/21/2013)... Paris, France: The Orsiro stent, which is a ... polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting ... late lumen loss at nine months in the ... 2013 today. , The BIOFLOW-II substudy used intravascular ... quantitatively assess neointimal hyperplasia and stent apposition at ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 According to ... to Rethink the Use of Botox,” Botox injections ... since their approval in 2002 (Go to goo.gl/8iYbD). Although it ... quite popular with men. The injection makes facial wrinkles less ... Botox injection last for about three months. This means that ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The ... on cable networks and cable channels across the country, ... on its YouTube channel. The producers of the series ... in the shipping industry, the manufacturing industry, health-related companies, ... medical facilities and medical practitioners in all parts of ...
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving ... residents in the Creative Corridor region, is releasing results ... news conference on Thursday, May 23rd at 10:30 a.m. ... 2008. , The survey is a critical ... efforts that attract, nurture and retain people of diverse ...
Breaking Medicine News(10 mins):Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2
... as patient engagement, physician communication, and staff coordination may ... patient survival rates than others, according to a study ... Journal of the American Society of Nephrology (CJASN). ... figure out what top-performing dialysis units might be doing ...
... will receive a $2.3 million New Innovator Award today ... platelets and the technology that makes them work. ... to build platelets of biodegradable polymers, which link with ... and fellow researchers initially pursued the technology after seeing ...
... (BMC) has been awarded a four year, $5.7 million ... (NHLBI) for investigators from Boston University School of Medicine ... Cardiovascular Outcomes and Disparities. The goal of the Center ... health reform on cardiovascular (CV) care and outcomes, and ...
... Gardner HealthDay Reporter , WEDNESDAY, Sept. 29 (HealthDay ... younger women finds that screening can lower the risk of ... The study, done in Sweden, found that women who were ... 1,250 women five times over a 10-year period would save ...
... Kang Zhang, MD, PhD, professor of ophthalmology at the ... director of UCSD,s Institute of Genomic Medicine, has been ... Zhang and co-principal investigators Sheng Ding, PhD, from ... the University of Washington, received the highest possible scores ...
... of immunotherapy to children with neuroblastoma, a nervous system ... and free of disease progression after two years, according ... School of Medicine and fellow institutions. The percentage rose ... to 66 percent for children receiving immunotherapy plus standard ...
Cached Medicine News:Health News:Why do some dialysis centers have higher survival rates? 2Health News:Researchers to study effects of Mass. health reform 2Health News:Mammograms Save Lives for Women in Their 40s, Study Says 2Health News:Mammograms Save Lives for Women in Their 40s, Study Says 3Health News:UCSD receives NIH Transformative R01 Award for stimulation of neuron regeneration in the retina 2Health News:UCSD receives NIH Transformative R01 Award for stimulation of neuron regeneration in the retina 3Health News:Addition of immunotherapy boosts pediatric cancer survival in children with neuroblastoma 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: